{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:45:27Z","timestamp":1790783127501,"version":"4.1.0"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To review susceptibility genes and how they could integrate in systemic sclerosis (SSc) pathophysiology providing insight and perspectives for innovative therapies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>SSc is a rare disease characterized by vasculopathy, dysregulated immunity and fibrosis. Genome-Wide association studies and ImmunoChip studies performed in recent years revealed associated genetic variants mainly localized in noncoding regions and mostly affecting the immune system of SSc patients. Gene variants were described in innate immunity (<jats:italic toggle=\"yes\">IRF5, IRF7<\/jats:italic> and <jats:italic toggle=\"yes\">TLR2<\/jats:italic>), T and B cells activation (<jats:italic toggle=\"yes\">CD247, TNFAIP3, STAT4<\/jats:italic> and <jats:italic toggle=\"yes\">BLK<\/jats:italic>) and NF-\u03baB pathway (<jats:italic toggle=\"yes\">TNFAIP3<\/jats:italic> and <jats:italic toggle=\"yes\">TNIP1<\/jats:italic>) confirming previous biological data. In addition to impacting immune response, <jats:italic toggle=\"yes\">CSK, DDX6, DNASE1L3<\/jats:italic> and <jats:italic toggle=\"yes\">GSDMA\/B<\/jats:italic> could also act in the vascular and fibrotic components of SSc.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Although genetic studies highlighted the dysregulated immune response in SSc, future research must focus on a deeper characterization of these variants with determination of their functional effects. Moreover, the role of these genes or others on specific vasculopathy and fibrosis would provide insight. Establishment of polygenic score or integrated genome approaches could identify new targets specific of SSc clinical features. This will allow physicians to propose new therapies to SSc patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000735","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T13:00:18Z","timestamp":1598014818000},"page":"505-514","source":"Crossref","is-referenced-by-count":46,"title":["Systemic sclerosis pathogenesis: contribution of recent advances in genetics"],"prefix":"10.1097","volume":"32","author":[{"given":"Cindy","family":"Orvain","sequence":"first","affiliation":[{"name":"INSERM U1016 UMR 8104, Institut Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servin","family":"Assassi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, The University of Texas Health Science Center at Houston, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Avouac","sequence":"additional","affiliation":[{"name":"INSERM U1016 UMR 8104, Institut Cochin, Paris, France"},{"name":"Department of Rheumatology, Cochin Hospital, Paris University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[{"name":"INSERM U1016 UMR 8104, Institut Cochin, Paris, France"},{"name":"Department of Rheumatology, Cochin Hospital, Paris University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin Epidemiol"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/art.24982","article-title":"HLA\u2013DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans","volume":"60","author":"Zhou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat Genet"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"e1002091","DOI":"10.1371\/journal.pgen.1002091","article-title":"Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis","volume":"7","author":"Allanore","year":"2011","journal-title":"PLoS Genet"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/annrheumdis-2016-210645","article-title":"Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis","volume":"76","author":"Terao","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1038\/s41467-019-12760-y","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"L\u00f3pez-Isac","year":"2019","journal-title":"Nat Commun"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","article-title":"Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis","volume":"94","author":"Mayes","year":"2014","journal-title":"Am J Hum Genet"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s13075-014-0438-8","article-title":"An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3","volume":"16","author":"Zochling","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/art.27224","article-title":"Systemic sclerosis and lupus: points in an interferon-mediated continuum","volume":"62","author":"Assassi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"A macrophage marker, siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type i interferons and toll-like receptor agonists","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat Genet"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/039463201402700420","article-title":"Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese","volume":"27","author":"Wang","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.celrep.2016.07.060","article-title":"IRF5 and IRF5 disease-risk variants increase glycolysis and human m1 macrophage polarization by regulating proximal signaling and Akt2 activation","volume":"16","author":"Hedl","year":"2016","journal-title":"Cell Rep"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/annrheumdis-2011-200901","article-title":"IRF5 polymorphism predicts prognosis in patients with systemic sclerosis","volume":"71","author":"Sharif","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2019-215208","article-title":"Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis","volume":"78","author":"Wu","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/annrheumdis-2011-200275","article-title":"Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis","volume":"71","author":"Carmona","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","article-title":"Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy","volume":"7","author":"Gorlova","year":"2011","journal-title":"PLoS Genet"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-015-0572-y","article-title":"Identification of NF-(B and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis","volume":"17","author":"Arismendi","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrrheum.2016.61","article-title":"Toll-like receptors and chronic inflammation in rheumatic diseases: new developments","volume":"12","author":"Joosten","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.33325","article-title":"A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators","volume":"64","author":"Broen","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1073\/pnas.1906593116","article-title":"HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry","volume":"117","author":"Gourh","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R28-20230829","first-page":"1751","article-title":"Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis","volume":"151","author":"Mavalia","year":"1997","journal-title":"Am J Pathol"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jid.2016.11.037","article-title":"Skin-resident effector memory CD8+CD28\u2013 T cells exhibit a profibrotic phenotype in patients with systemic sclerosis","volume":"137","author":"Li","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R30-20230829","first-page":"1252","article-title":"Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis","volume":"28","author":"Tsuji-Yamada","year":"2001","journal-title":"J Rheumatol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L","article-title":"Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis","volume":"42","author":"Atamas","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/ard.2010.147009","article-title":"Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor","volume":"70","author":"Dieude","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","article-title":"The significance of OX40 and OX40L to T-cell biology and immune disease","volume":"229","author":"Croft","year":"2009","journal-title":"Immunol Rev"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.2009.116434","article-title":"Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis","volume":"69","author":"Gourh","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2010.141838","article-title":"A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort","volume":"70","author":"Bossini-Castillo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.111270","article-title":"Independent replication and metaanalysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis","volume":"39","author":"Coustet","year":"2012","journal-title":"J Rheumatol"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"E3901","DOI":"10.1073\/pnas.1523512113","article-title":"OX40L blockade protects against inflammation-driven fibrosis","volume":"113","author":"Elhai","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/eci.11.31","article-title":"Targeting STAT4 in systemic sclerosis: a promising new direction","volume":"7","author":"Barnes","year":"2011","journal-title":"Exp Rev Clin Immunol"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","article-title":"The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype","volume":"18","author":"Rueda","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/ard.2009.111310","article-title":"Association of STAT4 polymorphism with systemic sclerosis in a Japanese population","volume":"68","author":"Tsuchiya","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/art.24958","article-title":"Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene\u2013gene interaction and alterations in Th1\/Th2 cytokines","volume":"60","author":"Gourh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.30171","article-title":"Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis","volume":"63","author":"Avouac","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1074\/jbc.M600498200","article-title":"Identification of substrates of human protein-tyrosine phosphatase PTPN22","volume":"281","author":"Wu","year":"2006","journal-title":"J Biol Chem"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/art.22196","article-title":"Association of thePTPN22 R620W polymorphism with anti\u2013topoisomerase I\u2013 and anticentromere antibody\u2013positive systemic sclerosis","volume":"54","author":"Gourh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.23601","article-title":"The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case\u2013control study of European Caucasians and a meta-analysis","volume":"58","author":"Dieud\u00e9","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/ard.2010.130138","article-title":"Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis","volume":"70","author":"Diaz-Gallo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1323","article-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","volume":"36","author":"Bottini","year":"2004","journal-title":"Nat Genet"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.10.015","article-title":"Altered B lymphocyte homeostasis and functions in systemic sclerosis","volume":"17","author":"Forestier","year":"2018","journal-title":"Autoimmun Rev"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/art.24885","article-title":"BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4: association of BANK1 with SSc","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2009.118174","article-title":"BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians","volume":"69","author":"Rueda","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaut.2009.08.014","article-title":"Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations","volume":"34","author":"Gourh","year":"2010","journal-title":"J Autoimmun"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/ard.2009.118760","article-title":"Replication of association between FAM167A(C8orf13)-BLK region and rheumatoid arthritis in a Japanese population","volume":"69","author":"Ito","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.30379","article-title":"C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysis","volume":"63","author":"Coustet","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fimmu.2018.00104","article-title":"A20\/Tumor necrosis factor -induced protein 3 in immune cells controls development of autoinflammation and autoimmunity: lessons from mouse models","volume":"9","author":"Das","year":"2018","journal-title":"Front Immunol"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/rheumatology\/kex280","article-title":"Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta","volume":"56","author":"McCoy","year":"2017","journal-title":"Rheumatology"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/ard.2009.127928","article-title":"Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population","volume":"69","author":"Dieud\u00e9","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.39476","article-title":"Identification of an association of TNFAIP3 polymorphisms with matrix metalloproteinase expression in fibroblasts in an integrative study of systemic sclerosis-associated genetic and environmental factors: TNFAIP3 polymorphisms and MMP expression in fibroblasts","volume":"68","author":"Wei","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/art.34490","article-title":"Brief Report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity","volume":"64","author":"Koumakis","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ng.202","article-title":"Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus","volume":"40","author":"Musone","year":"2008","journal-title":"Nat Genet"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13075-016-1118-7","article-title":"A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator","volume":"18","author":"Bhattacharyya","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R62-20230829","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/s41467-020-15022-4","article-title":"Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features","volume":"11","author":"Ray","year":"2020","journal-title":"Nat Commun"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/annrheumdis-2012-201888","article-title":"Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study","volume":"72","author":"Bossini-Castillo","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R64-20230829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.2018100010","article-title":"Precocious expression of Blimp1 in B cells causes autoimmune disease with increased self-reactive plasma cells","volume":"38","author":"B\u00f6nelt","year":"2019","journal-title":"EMBO J"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.38136","article-title":"Brief Report: a regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis: CCR6 regulatory variant in antitopoisomerase-positive SSc","volume":"65","author":"Koumakis","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"(4 Suppl 91)","key":"R66-20230829","first-page":"S31","article-title":"Confirmation of CCR6 as a risk factor for antitopoisomerase I antibodies in systemic sclerosis","volume":"33","author":"Ochoa","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/rheumatology\/kem352","article-title":"Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity","volume":"47","author":"Paunovic","year":"2008","journal-title":"Rheumatology"},{"key":"R68-20230829","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/hmg\/ddr522","article-title":"A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations","volume":"21","author":"Bossini-Castillo","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R69-20230829","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1002\/art.38870","article-title":"Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus: concise communication","volume":"66","author":"L\u00f3pez-Isac","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.immuni.2008.06.001","article-title":"A fundamental role for interleukin-21 in the generation of T follicular helper cells","volume":"29","author":"Vogelzang","year":"2008","journal-title":"Immunity"},{"key":"R71-20230829","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/art.20883","article-title":"Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis: altered expression pattern of keratinocytes in SSc","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R72-20230829","doi-asserted-by":"crossref","first-page":"eaaf5307","DOI":"10.1126\/scitranslmed.aaf5307","article-title":"T follicular helper\u2013like cells contribute to skin fibrosis","volume":"10","author":"Taylor","year":"2018","journal-title":"Sci Transl Med"},{"key":"R73-20230829","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/annrheumdis-2012-202357","article-title":"Implication of IL-2\/IL-21 region in systemic sclerosis genetic susceptibility","volume":"72","author":"Diaz-Gallo","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R74-20230829","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.3389\/fimmu.2018.02334","article-title":"Exploring the role of autophagy-related gene 5 (ATG5) yields important insights into autophagy in autoimmune\/autoinflammatory diseases","volume":"9","author":"Ye","year":"2018","journal-title":"Front Immunol"},{"key":"R75-20230829","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1074\/jbc.M112.420711","article-title":"Identification of DEAD-box RNA Helicase 6 (DDX6) as a cellular modulator of vascular endothelial growth factor expression under hypoxia","volume":"288","author":"de Vries","year":"2013","journal-title":"J Biol Chem"},{"key":"R76-20230829","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1742-4658.2008.06849.x","article-title":"Murine serum nucleases: contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3): murine serum nucleases","volume":"276","author":"Napirei","year":"2009","journal-title":"FEBS J"},{"key":"R77-20230829","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/annrheumdis-2017-212454","article-title":"Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk","volume":"77","author":"Moreno-Moral","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R78-20230829","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/art.23436","article-title":"Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis","volume":"58","author":"Skhirtladze","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R79-20230829","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/dds099","article-title":"Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up","volume":"21","author":"Martin","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R80-20230829","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/art.23791","article-title":"Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis","volume":"58","author":"Galdo","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R81-20230829","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/annrheumdis-2011-200986","article-title":"Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R82-20230829","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1073\/pnas.1411254111","article-title":"Tissue-specific regulation and function of Grb10 during growth and neuronal commitment","volume":"112","author":"Plasschaert","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"R83-20230829","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"R84-20230829","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.39449","article-title":"Identification of rare variants in ATP8B4 as a risk factor for systemic sclerosis by whole-exome sequencing: rare variants in APT8B4 and risk of SSc","volume":"68","author":"Gao","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R85-20230829","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/art.40058","article-title":"Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort","volume":"69","author":"L\u00f3pez-Isac","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R86-20230829","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/art.39721","article-title":"Brief Report: whole-exome sequencing for identification of potential causal variants for diffuse cutaneous systemic sclerosis: identification of potential dcSSc causal variants with WES","volume":"68","author":"Mak","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R87-20230829","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrg865","article-title":"Genetic analysis of African populations: human evolution and complex disease","volume":"3","author":"Tishkoff","year":"2002","journal-title":"Nat Rev Genet"},{"key":"R88-20230829","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/BOR.0b013e328356d9dc","article-title":"Racial differences between blacks and whites with systemic sclerosis","volume":"24","author":"Silver","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R89-20230829","doi-asserted-by":"crossref","first-page":"e8980","DOI":"10.1097\/MD.0000000000008980","article-title":"Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database","volume":"96","author":"Morgan","year":"2017","journal-title":"Medicine"},{"key":"R90-20230829","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"R91-20230829","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41588-019-0456-1","article-title":"A genetics-led approach defines the drug target landscape of 30 immune-related traits","volume":"51","author":"Fang","year":"2019","journal-title":"Nat Genet"},{"key":"R92-20230829","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1111\/jdv.14876","article-title":"The use of JAK inhibitors in the treatment of progressive systemic sclerosis","volume":"32","author":"Deverapalli","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:15:33Z","timestamp":1693293333000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000735","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]}}}